NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
(2S)-S-(5-chlorothiophen-2-yl)-4,4,4-trifluoro-1-hydroxy-3-(trifluoromethyl)butane-2-sulfonamido
|
|
|
IUPAC Traditional name
|
|
Synonyms
|
5-Chloro-N-[(1S)-3,3,3-trifluoro-1-(hydroxymethyl)-2-(trifluoromethyl)propyl]-2-thiophenesulfonamide
|
Begacestat
|
GSI 953
|
GSI-953
|
|
|
CAS Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
Data Source
|
Data ID
|
Price
|
TRC
|
|
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
Acid pKa
|
8.191627
|
H Acceptors
|
3
|
H Donor
|
2
|
LogD (pH = 5.5)
|
2.4232254
|
LogD (pH = 7.4)
|
2.364987
|
Log P
|
2.4240317
|
Molar Refractivity
|
64.7631 cm3
|
Polarizability
|
25.799778 Å3
|
Polar Surface Area
|
66.4 Å2
|
Rotatable Bonds
|
6
|
Lipinski's Rule of Five
|
true
|
PROPERTIES
PROPERTIES
Safety Information
Product Information
Bioassay(PubChem)
DETAILS
DETAILS
TRC
Toronto Research Chemicals -
G797400
|
Begacestat (GSI-953) is a selective β-secretase inhibitor that selectively inhibits cleavage of APP over Notch. GSI-953 is used for treating diseases such as cancer in relation to prevention of intestinal secretory metaplasia. |
REFERENCES
REFERENCES
From Suppliers
Google Scholar
PubMed
Google Books
- • van Es., et al.: Nature, 435, 959 (2005)
- • Morohashi., et al.: J. Biol. Chem., 281, 1467 (2005)
- • O'Neil., et al.: Neoplasia, 107, 781 (2005)
- • Mayer, et al.: J. Med. Chem., 51, 7348 (2005)
- • Martone, et al.: J. Pharmacol. Exp. Ther., 331, 598 (2005)
- Searching...Please wait...
PATENTS
PATENTS
PubChem Patent
Google Patent